MERIDIGEN BIOTECH CO LTD has a total of 26 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2014. It filed its patents most often in Taiwan, China and Singapore. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are BRUNO JOHN G, SEELIG RENATE and BIO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 7 | |
#2 | China | 5 | |
#3 | Singapore | 4 | |
#4 | United States | 4 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Japan | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Microorganisms | |
#3 | Measuring microorganism processes | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Hsuan Chang-Yo | 15 |
#2 | Lin Yun | 9 |
#3 | Liu Wei-Ting | 9 |
#4 | Lin Willie | 9 |
#5 | Su Yu-Chin | 8 |
#6 | Chang Chia-Chi | 6 |
#7 | Chang-Yo Hsuan | 6 |
#8 | Li Yuan-Tsung | 6 |
#9 | Shen Shih-Pei | 6 |
#10 | Wu Tang-Bo Chung | 5 |
Publication | Filing date | Title |
---|---|---|
TW202033764A | Composition for anti-aging | |
TW201913565A | Evaluation method for embryo images and system thereof | |
US2019060365A1 | Pharmaceutical composition for treating chronic obstructive pulmonary disease and method thereof | |
US2019054144A1 | Pharmaceutical composition for treating ischemic stroke and method thereof | |
US2018059109A1 | Method of distinguishing mesenchymal stem cells and method of determining purity of mesenchymal stem cells | |
SG10201800796XA | Method of distinguishing mesenchymal stem cells | |
TW201621047A | Method of distinguishing mesenchymal stem cells | |
US2016161483A1 | Method of distinguishing mesenchymal stem cells | |
KR20170071525A | Mmethod of distinguishing mesenchymal stem cells | |
TW201726912A | Method of distinguishing mesenchymal stem cells |